Literature DB >> 20100037

Rapid emergence of multimarker strategies in laboratory medicine.

D Gruson1, S Bodovitz.   

Abstract

A single biomarker has an inherent specificity and sensitivity that cannot be improved, but multiple biomarkers can be combined to achieve improved clinical performances. This is the basis of multimarker strategies that integrate different biomarkers into a single score to support medical decisions. The simplest strategy determines ratios of different biomarkers or the number of different markers above their respective thresholds. A more advanced strategy employs similar biomarkers, but uses more sophisticated algorithms. The most advanced strategy employs large numbers of biomarkers that may or may not have been previously characterized and uses sophisticated algorithms.

Mesh:

Substances:

Year:  2010        PMID: 20100037     DOI: 10.3109/13547500903560065

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  3 in total

Review 1.  Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests.

Authors:  Damien Gruson; Frédéric Thys; Franck Verschuren
Journal:  Mol Diagn Ther       Date:  2011-12-01       Impact factor: 4.074

Review 2.  Quantitation of endogenous peptides using mass spectrometry based methods.

Authors:  Elena V Romanova; Sarah E Dowd; Jonathan V Sweedler
Journal:  Curr Opin Chem Biol       Date:  2013-06-18       Impact factor: 8.822

3.  Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platform.

Authors:  Bas C T van Bussel; Isabel Ferreira; Marjo P H van de Waarenburg; Marleen M J van Greevenbroek; Carla J H van der Kallen; Ronald M A Henry; Edith J M Feskens; Coen D A Stehouwer; Casper G Schalkwijk
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.